---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/272026270.md"
description: "The A-share innovative drug sector surged in the afternoon, with WECOME rising over 15%, Frontier Biotechnologies and SHANGHAI YIZHONG rising over 10%, and JLPC, Hongbo Pharmaceutical, Genrix Bio, and Chengda Pharmaceutical following suit"
datetime: "2026-01-09T05:26:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/272026270.md)
  - [en](https://longbridge.com/en/news/272026270.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/272026270.md)
---

# 

The A-share innovative drug sector surged in the afternoon, with WECOME rising over 15%, Frontier Biotechnologies and SHANGHAI YIZHONG rising over 10%, and JLPC, Hongbo Pharmaceutical, Genrix Bio, and Chengda Pharmaceutical following suit

### Related Stocks

- [300878.CN](https://longbridge.com/en/quote/300878.CN.md)
- [688221.CN](https://longbridge.com/en/quote/688221.CN.md)
- [600513.CN](https://longbridge.com/en/quote/600513.CN.md)
- [688443.CN](https://longbridge.com/en/quote/688443.CN.md)
- [688091.CN](https://longbridge.com/en/quote/688091.CN.md)

## Related News & Research

- [China’s Frontier Biotech Wipes Out Gains Despite USD1 Billion Drug Licensing Deal With GSK](https://longbridge.com/en/news/276870046.md)
- [11:16 ETHaier ist die einzige IoT-Ökosystemmarke der Welt, die acht Jahre in Folge in die Kantar BrandZ Top 100 aufgenommen wurde](https://longbridge.com/en/news/286792596.md)
- [Manulife Singapore to offer multi-cancer blood test starting May](https://longbridge.com/en/news/286710691.md)
- [20:03 ETHarbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate](https://longbridge.com/en/news/286688082.md)
- [08:28 ETTERREPOWER Demonstrates Decarbonization and Resource Efficiency at Scale in 2025 Corporate Sustainability Report](https://longbridge.com/en/news/286912255.md)